Aehr Test Systems, Inc. AEHR
65.78 USD +6.21 (+10.42%)
At closeNov 12, 2026, 6:17 AM EST
63.25 -2.53 -3.85%
Pre-market · Nov 12, 6:17 AM ET
63.27 Day range 68.36
18.70 52-week range 147.40
- YTD
- +225.80%
- 1 year
- +184.02%
News
marketbeat.com Aehr Test Systems Notches Another Post-Earnings Win as Sales Triple on AI Demand AI stocks have experienced dramatic volatility over recent trading sessions. However, as investors weigh whether Democratic midterm victories could slow the AI infrastructure buildout, Aehr Test…
benzinga.com Nasdaq Jumps Over 200 Points as Chip Stocks Gain: Fear & Greed Index Remains in ‘Extreme Fear’ Zone Markets closed mixed as CNN Fear & Greed stayed at 19 (Extreme Fear); Nasdaq rose 0.83%, Dow fell, Apple dropped and Aehr surged 26%.
benzinga.com Lake Street Maintains Buy on Aehr Test System, Lowers Price Target to $90 Lake Street analyst Max Michaelis maintains Aehr Test System (NASDAQ:AEHR) with a Buy and lowers the price target from $110 to $90.
benzinga.com Jefferies Maintains Buy on Aehr Test System, Lowers Price Target to $140 Jefferies analyst Kevin Garrigan maintains Aehr Test System (NASDAQ:AEHR) with a Buy and lowers the price target from $175 to $140.
benzinga.com Nasdaq Surges 1%; Pfizer Posts Upbeat Q3 Earnings U.S. stocks were mixed as Nasdaq gained 1%; Pfizer beat Q3 estimates and raised 2026 guidance, while oil, gold and European shares fell.
benzinga.com 12 Information Technology Stocks Moving In Tuesday's Intraday Session Gainers Parabolic Technologies (NASDAQ:PARA) stock increased by 153.2% to $4.28 during Tuesday's regular session. Hub Cyber Security (NASDAQ:HUBC) shares increased by 40.6% to $0.12. Braiin…
benzinga.com Fabrinet, EverQuote, Lattice Semiconductor, Fiserv And Other Big Stocks Moving Higher On Tuesday U.S. stocks mixed as Dow fell 200 points; Fabrinet surged 13.7% on strong results, guidance and buyback, while several small caps rallied.
benzinga.com Aehr Stock Surges As CEO Says AI Chip Complexity Is Accelerating Burn-In Demand Aehr AI demand accelerates as chip complexity drives burn-in needs, hyperscale shipments ramp and fiscal 2027 guidance rises.
benzinga.com 12 Information Technology Stocks Moving In Tuesday's Pre-Market Session Gainers Backblaze (NASDAQ:BLZE) shares moved upwards by 33.2% to $9.86 during Tuesday's pre-market session. The market value of their outstanding shares is at $444.1 million. As per the news, the Q3…
benzinga.com Why Aehr Test Systems Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket Aehr surged 15% after strong Q1 results and raised FY27 guidance; Mercer, HUB Cyber and Parabolic led gainers, while VCIG and Jaguar fell.
benzinga.com Apple, Palantir, Marvell Technology, Oracle and Aehr Test Systems: Why These 5 Stocks Are on Investors' Radars Today Major indices closed mixed on Monday, with the Dow Jones Industrial Average gaining 0.41% to 51,983.98.
benzinga.com Aehr Test System Q1 2027 Earnings Call Transcript Aehr Test System (NASDAQ:AEHR) reported first-quarter financial results on Monday. The transcript from the company’s first-quarter earnings call has been provided below.This transcript is brought to…
benzinga.com Aehr Test Systems Stock Pops After Q1 Results: Here's Why Here's a detailed look inside the Q1 earnings report from Aehr Test Systems.
benzinga.com Aehr Test Systems Q1 Adj. EPS $0.28 Beats $0.11 Estimate, Sales $33.007M Beat $27.072M Estimate Aehr Test Systems (NASDAQ:AEHR) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.11 by 154.55 percent. This is a 2700 percent increase over earnings of…- benzinga.com Aehr Test System Raises FY2027 Sales Guidance from $130.000M-$150.000M to $150.000M vs $137.057M Est Aehr Test System (NASDAQ:AEHR) raises FY2027 sales outlook from $130.000 million-$150.000 million to $150.000 million vs $137.057 million estimate.
benzinga.com Silence Therapeutics, Disc Medicine, Veradermics And Other Big Stocks Moving Higher On Monday U.S. stocks mixed as Dow fell ~100 points; Silence Therapeutics surged 125.7% on Merck KGaA buyout, while biotech and tech shares gained.